Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001935979-26-000028
Filing Date
2026-03-13
Accepted
2026-03-13 16:54:52
Documents
19
Period of Report
2026-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A bhvn-20260313.htm   iXBRL DEF 14A 720231
3 bhvn-20260313_g1.jpg GRAPHIC 20335
4 bhvn-20260313_g2.jpg GRAPHIC 84292
5 bhvn-20260313_g3.jpg GRAPHIC 90952
6 bhvn-20260313_g4.jpg GRAPHIC 438544
7 bhvn-20260313_g5.jpg GRAPHIC 357889
8 bhvn-20260313_g6.jpg GRAPHIC 483087
9 bhvn-20260313_g7.jpg GRAPHIC 174090
  Complete submission text file 0001935979-26-000028.txt   4951175

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20260313.xsd EX-101.SCH 936
21 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20260313_htm.xml XML 58033
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Ltd. (Filer) CIK: 0001935979 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41477 | Film No.: 26753243
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)